Cargando…

Deep Learning Provides a New Magnetic Resonance Imaging-Based Prognostic Biomarker for Recurrence Prediction in High-Grade Serous Ovarian Cancer

This study aims to use a deep learning method to develop a signature extract from preoperative magnetic resonance imaging (MRI) and to evaluate its ability as a non-invasive recurrence risk prognostic marker in patients with advanced high-grade serous ovarian cancer (HGSOC). Our study comprises a to...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Lili, Wan, Haoming, Liu, Li, Wang, Jie, Tang, Yibo, Cui, Shaoguo, Li, Yongmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954966/
https://www.ncbi.nlm.nih.gov/pubmed/36832236
http://dx.doi.org/10.3390/diagnostics13040748
_version_ 1784894240551075840
author Liu, Lili
Wan, Haoming
Liu, Li
Wang, Jie
Tang, Yibo
Cui, Shaoguo
Li, Yongmei
author_facet Liu, Lili
Wan, Haoming
Liu, Li
Wang, Jie
Tang, Yibo
Cui, Shaoguo
Li, Yongmei
author_sort Liu, Lili
collection PubMed
description This study aims to use a deep learning method to develop a signature extract from preoperative magnetic resonance imaging (MRI) and to evaluate its ability as a non-invasive recurrence risk prognostic marker in patients with advanced high-grade serous ovarian cancer (HGSOC). Our study comprises a total of 185 patients with pathologically confirmed HGSOC. A total of 185 patients were randomly assigned in a 5:3:2 ratio to a training cohort (n = 92), validation cohort 1 (n = 56), and validation cohort 2 (n = 37). We built a new deep learning network from 3839 preoperative MRI images (T2-weighted images and diffusion-weighted images) to extract HGSOC prognostic indicators. Following that, a fusion model including clinical and deep learning features is developed to predict patients’ individual recurrence risk and 3-year recurrence likelihood. In the two validation cohorts, the consistency index of the fusion model was higher than both the deep learning model and the clinical feature model (0.752, 0.813 vs. 0.625, 0.600 vs. 0.505, 0.501). Among the three models, the fusion model had a higher AUC than either the deep learning model or the clinical model in validation cohorts 1 or 2 (AUC = was 0.986, 0.961 vs. 0.706, 0.676/0.506, 0.506). Using the DeLong method, the difference between them was statistically significant (p < 0.05). The Kaplan–Meier analysis distinguished two patient groups with high and low recurrence risk (p = 0.0008 and 0.0035, respectively). Deep learning may be a low-cost, non-invasive method for predicting risk for advanced HGSOC recurrence. Deep learning based on multi-sequence MRI serves as a prognostic biomarker for advanced HGSOC, which provides a preoperative model for predicting recurrence in HGSOC. Additionally, using the fusion model as a new prognostic analysis means that can use MRI data can be used without the need to follow-up the prognostic biomarker.
format Online
Article
Text
id pubmed-9954966
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99549662023-02-25 Deep Learning Provides a New Magnetic Resonance Imaging-Based Prognostic Biomarker for Recurrence Prediction in High-Grade Serous Ovarian Cancer Liu, Lili Wan, Haoming Liu, Li Wang, Jie Tang, Yibo Cui, Shaoguo Li, Yongmei Diagnostics (Basel) Article This study aims to use a deep learning method to develop a signature extract from preoperative magnetic resonance imaging (MRI) and to evaluate its ability as a non-invasive recurrence risk prognostic marker in patients with advanced high-grade serous ovarian cancer (HGSOC). Our study comprises a total of 185 patients with pathologically confirmed HGSOC. A total of 185 patients were randomly assigned in a 5:3:2 ratio to a training cohort (n = 92), validation cohort 1 (n = 56), and validation cohort 2 (n = 37). We built a new deep learning network from 3839 preoperative MRI images (T2-weighted images and diffusion-weighted images) to extract HGSOC prognostic indicators. Following that, a fusion model including clinical and deep learning features is developed to predict patients’ individual recurrence risk and 3-year recurrence likelihood. In the two validation cohorts, the consistency index of the fusion model was higher than both the deep learning model and the clinical feature model (0.752, 0.813 vs. 0.625, 0.600 vs. 0.505, 0.501). Among the three models, the fusion model had a higher AUC than either the deep learning model or the clinical model in validation cohorts 1 or 2 (AUC = was 0.986, 0.961 vs. 0.706, 0.676/0.506, 0.506). Using the DeLong method, the difference between them was statistically significant (p < 0.05). The Kaplan–Meier analysis distinguished two patient groups with high and low recurrence risk (p = 0.0008 and 0.0035, respectively). Deep learning may be a low-cost, non-invasive method for predicting risk for advanced HGSOC recurrence. Deep learning based on multi-sequence MRI serves as a prognostic biomarker for advanced HGSOC, which provides a preoperative model for predicting recurrence in HGSOC. Additionally, using the fusion model as a new prognostic analysis means that can use MRI data can be used without the need to follow-up the prognostic biomarker. MDPI 2023-02-16 /pmc/articles/PMC9954966/ /pubmed/36832236 http://dx.doi.org/10.3390/diagnostics13040748 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Liu, Lili
Wan, Haoming
Liu, Li
Wang, Jie
Tang, Yibo
Cui, Shaoguo
Li, Yongmei
Deep Learning Provides a New Magnetic Resonance Imaging-Based Prognostic Biomarker for Recurrence Prediction in High-Grade Serous Ovarian Cancer
title Deep Learning Provides a New Magnetic Resonance Imaging-Based Prognostic Biomarker for Recurrence Prediction in High-Grade Serous Ovarian Cancer
title_full Deep Learning Provides a New Magnetic Resonance Imaging-Based Prognostic Biomarker for Recurrence Prediction in High-Grade Serous Ovarian Cancer
title_fullStr Deep Learning Provides a New Magnetic Resonance Imaging-Based Prognostic Biomarker for Recurrence Prediction in High-Grade Serous Ovarian Cancer
title_full_unstemmed Deep Learning Provides a New Magnetic Resonance Imaging-Based Prognostic Biomarker for Recurrence Prediction in High-Grade Serous Ovarian Cancer
title_short Deep Learning Provides a New Magnetic Resonance Imaging-Based Prognostic Biomarker for Recurrence Prediction in High-Grade Serous Ovarian Cancer
title_sort deep learning provides a new magnetic resonance imaging-based prognostic biomarker for recurrence prediction in high-grade serous ovarian cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954966/
https://www.ncbi.nlm.nih.gov/pubmed/36832236
http://dx.doi.org/10.3390/diagnostics13040748
work_keys_str_mv AT liulili deeplearningprovidesanewmagneticresonanceimagingbasedprognosticbiomarkerforrecurrencepredictioninhighgradeserousovariancancer
AT wanhaoming deeplearningprovidesanewmagneticresonanceimagingbasedprognosticbiomarkerforrecurrencepredictioninhighgradeserousovariancancer
AT liuli deeplearningprovidesanewmagneticresonanceimagingbasedprognosticbiomarkerforrecurrencepredictioninhighgradeserousovariancancer
AT wangjie deeplearningprovidesanewmagneticresonanceimagingbasedprognosticbiomarkerforrecurrencepredictioninhighgradeserousovariancancer
AT tangyibo deeplearningprovidesanewmagneticresonanceimagingbasedprognosticbiomarkerforrecurrencepredictioninhighgradeserousovariancancer
AT cuishaoguo deeplearningprovidesanewmagneticresonanceimagingbasedprognosticbiomarkerforrecurrencepredictioninhighgradeserousovariancancer
AT liyongmei deeplearningprovidesanewmagneticresonanceimagingbasedprognosticbiomarkerforrecurrencepredictioninhighgradeserousovariancancer